Envista Holdings Corp
NYSE:NVSTMedical - Equipment & Services
+$0.76 today
- Market cap
- $3.81B
- Beta
- 0.89
- P/E (TTM)
- 62.0
- EPS (TTM)
- $0.41
Volume 1.92M
Average 2.94M
NVST Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Envista Holdings CorpNYSE: NVST
Research & Development · Q3 FY2026 · quarter ended Oct 2026
Research & development grows, but more slowly than its trailing trend
Q3 FY2026 research & development of $29.3M rose 3.5% year over year, behind the +12.2% change in trailing-twelve-month research & development. Sequentially, it fell 3.6% from the prior quarter. Over 3 fiscal years it compounded at +4.4% a year.
Context
- Research & development amounted to 4.2% of revenue in FY2025, up 0.2 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +3.5% toward the trailing-twelve-month pace of +12.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 114M USD
- Year-over-year change
- +15.0%
- 4-year CAGR
- +3.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 114M | +15.0% |
| FY2024 | 2024-12-31 | 99.1M | +5.7% |
| FY2023 | 2023-12-31 | 93.8M | -6.3% |
| FY2022 | 2022-12-31 | 100.1M | -0.4% |
| FY2021 | 2021-12-31 | 100.5M | — |
Research & Development vs competitors
How NVST compares with its peers on the latest reported figures
- NVST's LTM Oct 2026 research & development of $121.8M is the 7th highest of the 11 companies compared; the peer median is $142.05M.
- Its year-over-year change of +12.2% is the 5th highest of 8, against a peer median of +12.5%.
- Research & development amounts to 4.2% of revenue for NVST, versus a peer median of 4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $770.95M | +12.5% | +2.0% | 115.2% | |
| LTM Jun 2026 | $445.71M | +17.2% | +40.8% | — | |
| LTM Jun 2026 | $240.74M | +15.7% | +97.7% | — | |
| LTM Jun 2026 | $190.99M | -15.8% | -15.9% | 115.6% | |
| LTM Mar 2026 | $158M | -0.6% | -4.8% | 4.3% | |
| LTM Jun 2026 | $126.09M | +18.1% | +12.5% | 15.2% | |
| LTM Oct 2026 | $121.8M | +12.2% | +4.4% | 4.2% | |
| LTM Jun 2026 | $86.32M | -2.5% | -2.0% | 4.0% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NVST) | $142.05M | +12.5% | +2.0% | 4.1% | |
Competitors are the stored peer set for NVST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.51B | 2.57B | 2.57B | 2.51B | 2.72B |
| Cost of Revenue | 1.05B | 1.08B | 1.12B | 1.12B | 1.22B |
| Gross Profit | 1.46B | 1.49B | 1.45B | 1.39B | 1.5B |
| Gross Margin | 58.3% | 57.9% | 56.5% | 55.4% | 55.0% |
| Research & Development | 100.5M | 100.1M | 93.8M | 99.1M | 114M |
| Selling, General & Admin | 989.5M | 1.03B | 1.03B | 1.14B | 1.16B |
| Operating Expenses | 1.16B | 1.17B | 1.42B | 2.43B | 1.27B |
| Depreciation & Amortization | 151.9M | 162.1M | 162.6M | 123.1M | 116M |
| EBITDA | 524.3M | 522M | 490M | 279.5M | 329.8M |
| EBITDA Margin | 20.9% | 20.3% | 19.1% | 11.1% | 12.1% |
| Operating Income | 306.2M | 319.2M | 31.5M | (1.04B) | 225.7M |
| Operating Margin | 12.2% | 12.4% | 1.2% | -41.4% | 8.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 54.1M | 38.4M | 63.4M | 46.4M | 36.6M |
| Other Income / Expenses | (51.7M) | (35.3M) | (86.4M) | (46.5M) | (48.5M) |
| Income Before Tax | 254.5M | 283.9M | (54.9M) | (1.08B) | 177.2M |
| Pre-Tax Margin | 10.1% | 11.1% | -2.1% | -43.2% | 6.5% |
| Income Tax Expense | (9M) | 45.9M | 45.3M | 33.9M | 130.2M |
| Net Income | 340.5M | 243.1M | (100.2M) | (1.12B) | 47M |
| Net Margin | 13.6% | 9.5% | -3.9% | -44.6% | 1.7% |
| EPS (Basic) | 1.63 | 1.46 | (0.60) | (6.50) | 0.28 |
| EPS (Diluted) | 1.48 | 1.34 | (0.60) | (6.50) | 0.28 |
| Weighted Avg Shares | 161.2M | 162.9M | 166.9M | 172.2M | 168M |
| Weighted Avg Shares (Diluted) | 177.6M | 177.6M | 166.9M | 172.2M | 169.2M |
Envista Holdings Corp
NYSE:NVST
Intrinsic Alpha fair value
Locked
Current Price
$23.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.